Sara Y. Razi is Global Co-Chair of the Firm’s Antitrust and Trade Regulation Practice. She is a leading antitrust attorney focusing on merger reviews and clearance, government antitrust investigations, antitrust litigation, and counseling on competition issues.
Sara joined Simpson Thacher in 2013 from the FTC, where for nearly a decade she served in senior positions, including as an attorney advisor to Chairman Deborah Majoras and as a Deputy Assistant Director in the Bureau of Competition.
Sara represents clients in both M&A and civil antitrust matters across a very broad range of industries, including tech, health care, media, retail, and more. She represented Change Healthcare in its $13.8 billion acquisition by UnitedHealth Group, which won the Impact Case Award at Euromoney’s Benchmark Litigation Awards 2024, and was named “Merger Control Matter of the Year – Americas” at Global Competition Review’s GCR Awards 2023.
Recognized by The Legal 500 as a “Leading Lawyer” and by Chambers USA, Sara is also ranked as one of the “Top 250 Women in Litigation” in the U.S. by Euromoney’s Benchmark Litigation. In 2024, Euromoney’s Benchmark Litigation named Sara “Antitrust Litigator of the Year” and in 2023, The Deal named Sara among the “Top Women in Dealmaking.” She was also named “Antitrust & Competition Lawyer of the Year” in 2023 by Euromoney’s Women in Business Law Americas Awards, a 2023 Litigation “Trailblazer” by The National Law Journal, and a 2023 Law360 “MVP” in Competition/Antitrust.
Sara is a Board Member of the Legal Aid Society of the District of Columbia. She also serves as Co-Chair of the Firm’s Pro Bono Committee.
Sara earned her J.D., summa cum laude, from American University, Washington College of Law, and her B.A. in molecular, cellular and developmental biology from the University of Colorado.
Updated Oct 2024
